Cadence Pharmaceuticals is a biopharmaceutical company focused on in-licensing, developing and commercializing proprietary product candidates principally for use in the hospital setting.
View all » 
Recent Releases
May 8, 2013
Cadence Pharmaceuticals To Present At Three Investment Conferences During The Month Of May 2013
May 2, 2013
Cadence Pharmaceuticals Reports First Quarter 2013 Financial Results
View all »Events
May 30, 2013 at 11:20 AM ET
Deutsche Bank's 38th Annual Health Care Conference
May 21, 2013 at 2:00 PM ET
UBS Global Healthcare Conference 2013
| Stock Quote |
|---|
| CADX - (NASDAQ)
$6.70 - 0.29 May 22, 2013 4:00 PM ET |
Quotes delayed at
least 20 minutes.
Information provided
by eSignal.